Belimumab (Benlysta)
Belimumab is an immunosuppressant drug approved by the FDA for the treatment of lupus and lupus nephritis in children and adults. Belimumab is used in combination with other lupus drugs such as hydroxychloroquine and steroids.
"*" indicates required fields
